XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 214,093 $ 257,222
Accounts receivable, net 58,917 48,376
Inventory 43,865 39,756
Prepaid expenses and other current assets 5,017 5,213
Total current assets 321,892 350,567
Restricted cash, non-current 3,038 3,038
Property and equipment, net 27,675 28,748
Operating lease right-of-use assets, net 19,584 20,241
Intangible assets, net 1,068 1,204
Other assets 1,093 919
Total assets 374,350 404,717
Current liabilities:    
Accounts payable 9,950 13,499
Accrued compensation 14,882 16,885
Deferred revenue 6,552 5,656
Operating lease, current 1,769 1,683
Loan facility derivative liability 1,942 1,886
Other current liabilities 7,750 6,318
Total current liabilities 42,845 45,927
Long-term debt 51,404 51,339
Operating lease, non-current 27,843 26,182
Other liabilities 479 517
Total liabilities 122,571 123,965
Commitments and contingencies (see Note 11)
Stockholders’ equity:    
Preferred stock, $0.00001 par value; Authorized shares: 10,000 at March 31, 2024 and December 31, 2023, Issued and outstanding shares: none at March 31, 2024 and December 31, 2023 0 0
Common stock, $0.00001 par value; Authorized shares: 300,000 at March 31, 2024 and December 31, 2023 Issued and outstanding shares: 51,898 and 50,771 at March 31, 2024 and December 31, 2023, respectively 0 0
Additional paid-in capital 757,935 735,240
Accumulated other comprehensive gain (loss) (1) 84
Accumulated deficit (506,155) (454,572)
Total stockholders’ equity 251,779 280,752
Total liabilities and stockholders’ equity $ 374,350 $ 404,717